- Home
- USNA vs OCS Comparison
USNA vs OCS Comparison
Compare USNA & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- OCS
- Stock Information
- Founded
- USNA 1992
- OCS 2003
- Country
- USNA United States
- OCS Switzerland
- Employees
- USNA N/A
- OCS N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- USNA Health Care
- OCS Health Care
- Exchange
- USNA Nasdaq
- OCS Nasdaq
- Market Cap
- USNA 765.5M
- OCS 706.3M
- IPO Year
- USNA 1996
- OCS N/A
- Fundamental
- Price
- USNA $39.33
- OCS $14.75
- Analyst Decision
- USNA Hold
- OCS Strong Buy
- Analyst Count
- USNA 1
- OCS 5
- Target Price
- USNA $35.00
- OCS $29.20
- AVG Volume (30 Days)
- USNA 81.7K
- OCS 58.2K
- Earning Date
- USNA 10-22-2024
- OCS 11-07-2024
- Dividend Yield
- USNA N/A
- OCS N/A
- EPS Growth
- USNA N/A
- OCS N/A
- EPS
- USNA 2.83
- OCS N/A
- Revenue
- USNA $861,973,000.00
- OCS $1,027,571.00
- Revenue This Year
- USNA N/A
- OCS $4.38
- Revenue Next Year
- USNA N/A
- OCS $905.09
- P/E Ratio
- USNA $14.08
- OCS N/A
- Revenue Growth
- USNA N/A
- OCS N/A
- 52 Week Low
- USNA $34.15
- OCS $9.60
- 52 Week High
- USNA $54.81
- OCS $18.00
- Technical
- Relative Strength Index (RSI)
- USNA 53.25
- OCS 44.19
- Support Level
- USNA $38.55
- OCS $14.00
- Resistance Level
- USNA $41.52
- OCS $15.43
- Average True Range (ATR)
- USNA 1.05
- OCS 0.70
- MACD
- USNA -0.07
- OCS -0.30
- Stochastic Oscillator
- USNA 44.96
- OCS 18.75
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.